PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19
PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30 countries by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD). This test is currently under review by the U.S. FDA for Emergency Use Authorization (EUA). The multi-analyte panel enables labs to detect and differentiate between SARS-CoV-2, influenza A viruses, influenza B viruses and respiratory syncytial virus (RSV) in a single test, which will be critical to manage the surge in test demand during the flu season as the targeted pathogens have some similar signs and symptoms.
Rather than running multiple tests on samples, the PKamp Respiratory SARS-CoV-2 RT-PCR Panel is designed to conserve resources by testing a single nasopharyngeal, oropharyngeal or nasal swab sample collected from individuals suspected of respiratory viral infection consistent with COVID-19, the flu and RSV. Building off the most sensitive SARS-CoV-2 test kit in the market according to the FDA’s reference panel comparative data, the multi-analyte panel is designed to be used with PerkinElmer’s automated viral nucleic extractor to detect smaller amounts of viral material in samples.
“In the next few months, it will be vital for health professionals to detect and differentiate between COVID-19, the common flu and RSV infection,” said Masoud Toloue, Ph.D., Vice President and General Manager, Diagnostics, PerkinElmer. “By offering an automated multi-analyte testing solution, we are equipping diagnostics labs with the right toolset to tackle the additional pressure the season may have on this pandemic.”
PerkinElmer continues to work with specialty and reference diagnostic labs, clinics, hospitals, pharmaceutical and biopharmaceutical labs, academia, and governmental and research institutes to battle the pandemic. PerkinElmer’s comprehensive SARS-CoV-2 offerings span high throughput RNA extraction, RT-PCR, automation, ELISA, chemiluminescence, time-resolved fluorescence and lateral flow based serology testing.
About PerkinElmer
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food, and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201026005308/en/
Contact information
Media Relations:
Chet Murray
(781) 663-5719
chet.murray@perkinlelmer.com
Investor Relations:
Bryan Kipp
(781) 663-5583
bryan.kipp@perkinelmer.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The LYCRA Company Announces Grand Opening of Its Largest Global Spandex Production Facility in China10.11.2025 14:00:00 EET | Press release
The LYCRA Company, a global leader in innovative and sustainable fiber solutions for the apparel and personal care industries, today announced the official opening of its largest spandex production facility—the LYCRA® fiber (Yinchuan) Plant in Ningxia Province, China. This milestone underscores the company’s continued investment in the Chinese market and highlights its strong commitment to developing localized supply and distribution networks while advancing smart manufacturing upgrades. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110715151/en/ Executives and local dignitaries gathered to celebrate the grand opening of The LYCRA Company's state-of-the-art spandex manufacturing facility in Yinchuan, China, on November 7, marking a significant milestone in regional investment and the company's strong commitment to developing localized supply and distribution networks. With a total investment of more than RMB 800 million,
71% of Global Businesses Have Accelerated AI Adoption Amid Tariffs, Inflation and Uncertainty, Finds Economist Study Commissioned by Kinaxis10.11.2025 14:00:00 EET | Press release
According to Supply Chain’s Big Bet on AI For Geopolitical Resilience, a new global study from Economist Impact, commissioned by Kinaxis® Inc. (TSX:KXS), while 71% of companies have accelerated AI deployment in response to tariffs, inflation, and geopolitical volatility, a wide gap remains between AI ambition and implementation, according to Economist Impact. Nearly every company (97%) is experimenting with AI, but only 20% can make real-time decisions, and just 22% have a defined AI strategy, and those with one are more than three times as likely to see measurable ROI. Moreover, while business leaders tend to underestimate the new risks and complexities that AI may introduce, staff are more focused on the practical realities with the effort, change management, and technical challenges involved in turning AI ambition into everyday impact. “Disruption is no longer cyclical, it’s structural, and AI has become the defining accelerator of adaptability,” said Fab Brasca, Senior Vice Preside
Venture Global Announces Long-term Sales and Purchase Agreement With Naturgy of Spain10.11.2025 14:00:00 EET | Press release
Today, Venture Global, Inc. (NYSE:VG) and Naturgy announced the execution of a new long-term Sales and Purchase Agreement (SPA) for the purchase of 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global for twenty years beginning in 2030. The agreement represents Spain’s first long-term contract for American LNG since Venture Global’s first contract in 2018. To date, Venture Global has supplied Spain with 35 cargoes from its Calcasieu Pass and Plaquemines facilities. “Venture Global is honored to expand our long-term partnership with Spain through this new agreement with Naturgy, a leading global LNG company,” said Mike Sabel, CEO of Venture Global. “This contract will positively impact the U.S. balance of trade with Spain and enhance energy security across the region. Our unmatched speed and execution have made Venture Global a trusted, reliable supplier to the global market. The signing of this agreement, along with the strong commercial momentum we’ve a
Ookla Unveils Speedtest Pulse™, Redefining Network Validation and Troubleshooting10.11.2025 13:00:00 EET | Press release
Ookla®, a global leader in connectivity intelligence, today unveiled Speedtest Pulse™, a new network diagnostic device designed to provide definitive, smartphone-based validation and troubleshooting for internet service providers (ISPs) and enterprises. Leveraging the power of Speedtest®, a globally trusted gold standard for connectivity measurement, Speedtest Pulse bridges a crucial gap in technician toolkits, offering a powerful, scalable solution that is easy to use and provides clear, actionable insights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110605367/en/ Speedtest Pulse™ is a dual-mode network diagnostic tool offering one-tap, smartphone-based validation and troubleshooting, and autonomous testing of network performance and user experience. The launch comes at a pivotal inflection point for the industry. Wi-Fi is no longer a commodity; it is critical infrastructure for modern homes and businesses. It serves
Kaneka Expands Global Reach with i-ED COIL™ Launch in Europe10.11.2025 04:51:00 EET | Press release
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) has begun sales of its i-ED COIL™, a brain aneurysm embolization coil (*1), in Europe as of October. The product obtained EC certification (*2) under an EU Medical Device Regulation (*3) in July and will be distributed primarily in Europe through Kaneka Medical Europe N.V. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251109744229/en/ i-ED Coil The i-ED COIL™ provides world-class flexibility, enabled by its specialized wire thickness and structural features. This flexibility enables coils to be packed more densely within aneurysms than conventional products and allows treatment of aneurysms with irregular shapes. Its role in reducing the risk of aneurysm rupture is highly regarded by physicians, and since its launch in the Japanese market in 2019, sales have continued to grow steadily. Kaneka is expanding its business in a wide range
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom